PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease
This article is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Review previously published in the Cochrane Database of Systematic Reviews. Original publication: Schmidt AF, Carter J-PL, Pearce LS, Wilkins JT, Overington JP, Hingorani AD, Casas J. PCSK9 monoclonal antibod...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2023-12-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343395289366528 |
|---|---|
| author | article Editorial |
| author_facet | article Editorial |
| author_sort | article Editorial |
| collection | DOAJ |
| description | This article is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Review previously published in the Cochrane Database of Systematic Reviews. Original publication: Schmidt AF, Carter J-PL, Pearce LS, Wilkins JT, Overington JP, Hingorani AD, Casas J. PCSK9 monoclonal antibodies for the primary and secon dary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2020, Issue 10. Art. No.: CD011748. https://doi.org/10.1002/14651858.CD011748.pub3 |
| format | Article |
| id | doaj-art-543ae7d67e4240c8baaed6a2093c8937 |
| institution | Kabale University |
| issn | 2312-7821 2619-1164 |
| language | Russian |
| publishDate | 2023-12-01 |
| publisher | Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| record_format | Article |
| series | Безопасность и риск фармакотерапии |
| spelling | doaj-art-543ae7d67e4240c8baaed6a2093c89372025-08-20T03:43:01ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642023-12-0111447347410.30895/2312-7821-2023-11-4-473-474326PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Diseasearticle EditorialThis article is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Review previously published in the Cochrane Database of Systematic Reviews. Original publication: Schmidt AF, Carter J-PL, Pearce LS, Wilkins JT, Overington JP, Hingorani AD, Casas J. PCSK9 monoclonal antibodies for the primary and secon dary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2020, Issue 10. Art. No.: CD011748. https://doi.org/10.1002/14651858.CD011748.pub3https://www.risksafety.ru/jour/article/view/412pcsk9 monoclonal antibodiescardiovascular diseasepreventionalirocumabevolocumabcochrane review |
| spellingShingle | article Editorial PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease Безопасность и риск фармакотерапии pcsk9 monoclonal antibodies cardiovascular disease prevention alirocumab evolocumab cochrane review |
| title | PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease |
| title_full | PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease |
| title_fullStr | PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease |
| title_full_unstemmed | PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease |
| title_short | PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease |
| title_sort | pcsk9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease |
| topic | pcsk9 monoclonal antibodies cardiovascular disease prevention alirocumab evolocumab cochrane review |
| url | https://www.risksafety.ru/jour/article/view/412 |
| work_keys_str_mv | AT articleeditorial pcsk9monoclonalantibodiesfortheprimaryandsecondarypreventionofcardiovasculardisease |